According to The Insight Partners market research study titled ‘Liver treatment Market to 2025 " Global
Analysis and Forecasts by disease and imaging modality, the global liver
treatment market is expected to reach US$ 4,883.5 Mn in 2025 from US$ 3,426.8
in 2017. The market is estimated to grow with a CAGR of 4.6% from 2018-2025.
The report highlights the trends prevalent in the global liver treatment market
and the factors driving the market along with those that act as deterrents to
its growth.
Get the inside scope of the Sample report
Global liver treatment market, based on the diseases, is segmented into cancer,
hepatitis, cirrhosis, and other diseases. In 2017, cancer held the largest
market share. There has been a significant increase in the number of liver
cancer cases due to hepatitis infections, smoking, over consumption of alcohol,
and obesity. Cancer is also expected to be the fastest growing segment and is
likely to grow at the highest growth rate during the forecast period. This
attributes to the rapidly increasing number of patients suffering with the
disease that requires appropriate diagnosis and treatment options.
Key factors such as increasing prevalence of liver diseases, rising geriatric
population suffering from liver diseases and various technological advancements
in imaging techniques are key drivers for the growth of the market. However,
factors such as stringent regulatory framework and high cost of imaging
techniques for liver treatment are likely to restrain the market growth to a
certain extent. One the other hand, partnerships and collaborations among
industry players and increasing expenditures among emerging markets are
expected to provide significant opportunities to the players in the liver
treatment market.
Key market players operating in the market of liver treatment across the globe
includes General Electric, Koninklijke Philips N.V., Siemens AG, CANON MEDICAL
SYSTEMS CORPORATION, Hitachi, Ltd, Elekta AB (pub), Neusoft Corporation,
Samsung Healthcare, BPL Medical Technologies, and Cura Healthcare. The
manufacturing companies are launching innovative products in the market to
retain their significance in the highly competitive global scenario. For
instance, in November 2017, Canon Medical Systems introduced the new package
for its iSeries scanners. The series will include Aplio i700, i800, and i900
which will be assessing the liver in the patients suffering from fatty liver
diseases. The developments performed by the companies are helping the market to
grow in the coming years.
The report segments the global liver treatment market as follows:
Global Liver treatment Market " By Disease
Cancer
Hepatitis
Cirrhosis
Others
Global Liver treatment Market " By Imaging Modality
Computed Tomography
Magnetic Resonance Imaging
Ultrasound
Others
Global Liver treatment Market " By Geography
North America
U.S.
Canada
Mexico
Europe
U.K.
Germany
France
Asia Pacific (APAC)
Japan
China
India
Middle East & Africa (MEA)
Turkey
South Africa
UAE
Saudi Arabia
South & Central America (SCAM)
Brazil
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: [email protected]